Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge – Baltimore Sun

Arthur Allen | (TNS) KFF Health NewsWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July. His tumors shrank, then stabilized.But while the drug has helped keep him alive, its…